Teaching hospital Program year 2025 Source: CMS Open Payments

Montefiore Medical Center

NY

CCN 330059 CMS hospital 16487

Open in the dashboard

General payments

$45,411,627

3,621 payments

Research payments

$23,985,325

1,905 payments

Through program year 2025, Montefiore Medical Center is reported as receiving $45,411,627 in general payments and $23,985,325 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $5,524,566 370
2025 Research $1,689,206 256
2024 General $4,624,903 539
2024 Research $1,334,247 223
2023 General $4,969,668 474
2023 Research $2,065,072 191
2022 General $8,852,544 645
2022 Research $4,631,273 198
2021 General $5,338,623 692
2021 Research $3,783,429 336
2020 General $8,075,455 484
2020 Research $4,179,663 313
2019 General $8,025,867 417
2019 Research $6,302,436 388

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $10,908,721 1,784 payments
  2. Allergan Inc. $6,467,738 656 payments
  3. Merck Sharp & Dohme Corporation $2,063,667 27 payments
  4. Janssen Pharmaceuticals, Inc $1,654,500 3 payments
  5. Pfizer Inc. $1,591,185 14 payments
  6. Genentech, Inc. $1,533,090 18 payments
  7. Gilead Sciences, Inc. $1,508,315 12 payments
  8. Janssen Scientific Affairs, LLC $1,388,261 25 payments
  9. Bayer HealthCare Pharmaceuticals Inc. $1,250,000 7 payments
  10. Amgen Inc. $1,033,000 14 payments
  11. Other $16,013,149 1,061 payments
What the payments were for General payments · program years 2019–2025
  1. Grant $40,252,868 2,831 payments
  2. Education $2,186,859 108 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $912,812 113 payments
  4. Space rental or facility fees (teaching hospital only) $855,737 198 payments
  5. Long term medical supply or device loan $497,916 212 payments
  6. Charitable Contribution $233,776 14 payments
  7. Debt forgiveness $132,051 44 payments
  8. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $100,000 1 payment
  9. Gift $92,391 52 payments
  10. Consulting Fee $89,186 25 payments
  11. Other $58,031 23 payments
Products named General payments · program years 2019–2025
  1. Xarelto $1,654,500 3 payments
  2. APC Flash-Free Clarity ADVANCED $769,026 2 payments
  3. Exparel $587,563 20 payments
  4. Alinity m $570,225 44 payments
  5. 3M Unitek $397,116 1 payment
  6. Transbond Plus Orthodontic Bonding $397,116 1 payment
  7. Botox $372,185 393 payments
  8. Transbond Plus Orthodontic Bonding $371,910 1 payment
  9. Clarity ADVANCED $371,910 1 payment
  10. Imbruvica $355,000 4 payments
  11. Other $5,174,860 882 payments

A payment can name more than one product, so these amounts overlap.

3,621 general · 1,905 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record